Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
57 GaraciE.PalamaraA
You want pros handling this
Nature 603 , 885892 (2022)
As GLP-1 receptor agonists move beyond blood sugar and weight loss, a new review shows why clinicians must pair their growing promise with sharper monitoring, safer prescribing, and fairer access
Results Patient population We included 78,781 patients who had both a prescription for a GLP-1 receptor agonist (GLP-1 RA) and a documented reason for discontinuing the medication between June 2021 and December 2024 (Table 1)
US$ 21.29
US$ 22.61
US$ 26.13
US$ 21.23
US$ 29.44
US$ 22.71
US$ 24.74
US$ 24.07
US$ 26.51
